BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25794711)

  • 1. Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief. Authors' reply.
    Schmitt C; Sako N; Bagot M; Bensussan A
    Am J Pathol; 2015 Apr; 185(4):1168. PubMed ID: 25794711
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief.
    Küçük C; Hu X; McKeithan T; Chan WC
    Am J Pathol; 2015 Apr; 185(4):1167-8. PubMed ID: 25794710
    [No Abstract]   [Full Text] [Related]  

  • 3. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular underpinning of extranodal NK/T-cell lymphoma.
    Huang Y; de Leval L; Gaulard P
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
    Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
    J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
    Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
    J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
    Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
    Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
    Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
    Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.
    Zhang X; Ji W; Huang R; Li L; Wang X; Li L; Fu X; Sun Z; Li Z; Chen Q; Zhang M
    Oncotarget; 2016 Aug; 7(33):53808-53819. PubMed ID: 27462776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
    Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
    Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system extranodal NK/T cell lymphoma, nasal type, with antecedent hemophagocytic syndrome in a child.
    Jiang X; Yin W; Song J; Chen X; Zhao C; Wen F
    Pediatr Dev Pathol; 2014; 17(6):482-6. PubMed ID: 25207703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
    Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
    Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells.
    Bouzelfen A; Kora H; Alcantara M; Bertrand P; Latouche JB; Jardin F
    Leuk Res; 2017 Sep; 60():53-57. PubMed ID: 28651105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal extranodal NK/T-cell lymphoma, nasal type: retrospective study of 18 consecutive cases in Guangzhou, China.
    Huang YH; Wu QL; Zong YS; Feng YF; Hou JH
    Int J Surg Pathol; 2011 Feb; 19(1):51-61. PubMed ID: 21134987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
    Chang BH; Stork L; Fan G
    Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
    Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
    J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma.
    Fu L; Gao Z; Zhang X; Tsang YH; Goh HK; Geng H; Shimizu N; Tsuchiyama J; Srivastava G; Tao Q
    Int J Cancer; 2009 Apr; 124(7):1572-8. PubMed ID: 19115211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.
    Küçük C; Hu X; Jiang B; Klinkebiel D; Geng H; Gong Q; Bouska A; Iqbal J; Gaulard P; McKeithan TW; Chan WC
    Clin Cancer Res; 2015 Apr; 21(7):1699-711. PubMed ID: 25614448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.